AC Immune SA

From Verify.Wiki
Jump to: navigation, search
Aci.png
www.acimmune.com
AC Immune SA
Type Public
Industry Biotechnology
Founded 2003
Headquarters Lausanne, Switzerland
Key people Andrea Pfeifer (Co-Founder & CEO), Jean-Fabien Monin (CFO), Andreas Muhs (CSO) [1]
Investors Dietmar Hopp
Number of employees 62 [2]

AC Immune SA, a clinical stage Swiss-based biopharmaceutical company, focuses on neurodegenerative diseases with three product candidates in clinical trials. It designs, discovers, and develops therapeutic and diagnostic products intended to prevent and modify diseases caused by misfolding proteins. The company’s technology platforms create antibodies, small molecules, and vaccines to address a broad spectrum of neurodegenerative indications. It offers its therapies to address Alzheimer disease and neurodegenerative diseases, such as Parkinson’s, Down syndrome, and glaucoma.
AC Immune SA was founded in 2003 and is based in Lausanne, Switzerland. [3]

History

Controversies

Top 5 Recent Tweets

DateAuthorComment
November 13, 2018registrarjournAC Immune SA $ACIU Receives Average Rating of “Hold” from Analysts https://t.co/4KWLsmmrVI
November 13, 2018EnterpriseLeadeAC Immune SA $ACIU Receives Average Rating of “Hold” from Analysts https://t.co/ETtNREfehn
November 13, 2018AmericanBankingAC Immune SA $ACIU Receives Consensus Recommendation of “Hold” from Analysts https://t.co/IjcF6Vr1JN #stocks
November 12, 2018HIV_AIDS_BioAC Immune to Present at the Jefferies 2018 London Healthcare Conference: Lausanne Switzerland November 12 2018 AC I… https://t.co/thy1n8Zzw9


Top 5 Recent News Headlines

Top 5 Lifetime Tweets

Top 5 Lifetime News Headlines

  1. http://www.acimmune.com/en/senior-management-team/
  2. http://www.nasdaq.com/markets/ipos/company/ac-immune-sa-995734-81000
  3. http://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=22309440

Verification history